Wnt/β-Catenin Signaling Mediates Antineoplastic Effects of Imatinib Mesylate (Gleevec) in Anaplastic Thyroid Cancer

Annavarapu Srinivas Rao, Natalia Kremenevskaja, Reinhard von Wasielewski, Vladimira Jakubcakova, Shashi Kant, Julia Resch, Georg Brabant

Open source

DOI: 10.1210/jc.2005-1381
Published: 2006-01
Container: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Open access: unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1210/jc.2005-1381,
  title = {Wnt/β-Catenin Signaling Mediates Antineoplastic Effects of Imatinib Mesylate (Gleevec) in Anaplastic Thyroid Cancer},
  author = {Annavarapu Srinivas Rao and Natalia Kremenevskaja and Reinhard von Wasielewski and Vladimira Jakubcakova and Shashi Kant and Julia Resch and Georg Brabant},
  year = {2006},
  journal = {The Journal of Clinical Endocrinology \&amp; Metabolism},
  doi = {10.1210/jc.2005-1381},
  url = {https://doi.org/10.1210/jc.2005-1381}
}

RIS

TY  - JOUR
TI  - Wnt/β-Catenin Signaling Mediates Antineoplastic Effects of Imatinib Mesylate (Gleevec) in Anaplastic Thyroid Cancer
AU  - Annavarapu Srinivas Rao
AU  - Natalia Kremenevskaja
AU  - Reinhard von Wasielewski
AU  - Vladimira Jakubcakova
AU  - Shashi Kant
AU  - Julia Resch
AU  - Georg Brabant
PY  - 2006
JO  - The Journal of Clinical Endocrinology &amp; Metabolism
DO  - 10.1210/jc.2005-1381
UR  - https://doi.org/10.1210/jc.2005-1381
ER  -

APA

Rao, A. S., Kremenevskaja, N., Wasielewski, R. V., Jakubcakova, V., Kant, S., Resch, J., & Brabant, G. (2006). Wnt/β-Catenin Signaling Mediates Antineoplastic Effects of Imatinib Mesylate (Gleevec) in Anaplastic Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2005-1381

Source records

crossref · retrieved 2026-09-26T07:35:38.038Z